Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Cellyan Biotechnology Co., Ltd (HKPD) had Receiveable Turnover of 1.14 for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$13.43M |
|
$-1.14M |
|
$12.05M |
|
$1.39M |
|
$14.43M |
|
$-1.00M |
|
$-0.13M |
|
$-1.13M |
|
$-1.13M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.00M |
|
$-0.91M |
|
16.35M |
|
16.35M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$12.33M |
|
$0.06M |
|
$0.51M |
|
$12.84M |
|
$3.20M |
|
$0.07M |
|
$0.07M |
|
$3.26M |
|
$9.58M |
|
$9.51M |
|
$9.58M |
|
23.50M |
|
| Cash Flow Statement Financials | |
$-0.75M |
|
$0.86M |
|
$-0.63M |
|
$0.75M |
|
$0.22M |
|
$-0.53M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.86 |
|
-- |
|
-- |
|
0.01 |
|
0.13 |
|
10.32% |
|
-7.45% |
|
-7.45% |
|
-6.80% |
|
-8.40% |
|
-8.46% |
|
$-0.79M |
|
-- |
|
-- |
|
-- |
|
1.05 |
|
33.45 |
|
|
Receiveable Turnover |
1.14 |
319.30 |
|
-11.85% |
|
-11.95% |
|
-8.84% |
|
-11.77% |
|
$0.41 |
|
$-0.05 |
|
$-0.05 |
|